Literature DB >> 25905980

Race, Relationship and Renal Diagnoses After Living Kidney Donation.

Krista L Lentine1, Mark A Schnitzler, Amit X Garg, Huiling Xiao, David Axelrod, Janet E Tuttle-Newhall, Daniel C Brennan, Dorry L Segev.   

Abstract

BACKGROUND: In response to recent studies, a better understanding of the risks of renal complications among African American and biologically related living kidney donors is needed.
METHODS: We examined a database linking U.S. registry identifiers for living kidney donors (1987-2007) to billing claims from a private health insurer (2000-2007 claims) to identify renal condition diagnoses categorized by International Classification of Diseases 9th Revision coding. Cox regression with left and right censoring was used to estimate cumulative incidence of diagnoses after donation and associations (adjusted hazards ratios, aHR) with donor traits.
RESULTS: Among 4650 living donors, 13.1% were African American and 76.3% were white; 76.1% were first-degree relatives of their recipient. By 7 years post-donation, after adjustment for age and sex, greater proportions of African American compared with white donors had renal condition diagnoses: chronic kidney disease (12.6% vs 5.6%; aHR, 2.32; 95% confidence interval [95% CI], 1.48-3.62), proteinuria (5.7% vs 2.6%; aHR, 2.27; 95% CI, 1.32-3.89), nephrotic syndrome (1.3% vs 0.1%; aHR, 15.7; 95% CI, 2.97-83.0), and any renal condition (14.9% vs 9.0%; aHR, 1.72; 95% CI, 1.23-2.41). Although first-degree biological relationship to the recipient was not associated with renal risk, associations of African American race persisted for these conditions and included unspecified renal failure and reported disorders of kidney dysfunction after adjustment for biological donor-recipient relationship.
CONCLUSIONS: African Americans more commonly develop renal conditions after living kidney donation, independent of donor-recipient relationship. Continued research is needed to improve risk stratification for renal outcomes among African American living donors.

Entities:  

Mesh:

Year:  2015        PMID: 25905980      PMCID: PMC4663050          DOI: 10.1097/TP.0000000000000733

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  37 in total

1.  When good intentions are not enough: obtaining follow-up data in living kidney donors.

Authors:  E S Ommen; D LaPointe Rudow; R K Medapalli; B Schröppel; B Murphy
Journal:  Am J Transplant       Date:  2011-11-04       Impact factor: 8.086

2.  Very long-term follow-up of living kidney donors.

Authors:  Catherine Fournier; Nicolas Pallet; Zoubair Cherqaoui; Sylvie Pucheu; Henri Kreis; Arnaud Méjean; Marc-Olivier Timsit; Paul Landais; Christophe Legendre
Journal:  Transpl Int       Date:  2012-02-22       Impact factor: 3.782

3.  Sensitivity of billing claims for cardiovascular disease events among kidney transplant recipients.

Authors:  Krista L Lentine; Mark A Schnitzler; Kevin C Abbott; Kosha Bramesfeld; Paula M Buchanan; Daniel C Brennan
Journal:  Clin J Am Soc Nephrol       Date:  2009-06-18       Impact factor: 8.237

4.  African American living-kidney donors should be screened for APOL1 risk alleles.

Authors:  David M Cohen; Anuja Mittalhenkle; David L Scott; Carlton J Young; Douglas J Norman
Journal:  Transplantation       Date:  2011-10-15       Impact factor: 4.939

5.  The APOL1 gene and allograft survival after kidney transplantation.

Authors:  A M Reeves-Daniel; J A DePalma; A J Bleyer; M V Rocco; M Murea; P L Adams; C D Langefeld; D W Bowden; P J Hicks; R J Stratta; J-J Lin; D F Kiger; M D Gautreaux; J Divers; B I Freedman
Journal:  Am J Transplant       Date:  2011-04-12       Impact factor: 8.086

6.  APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.

Authors:  Jeffrey B Kopp; George W Nelson; Karmini Sampath; Randall C Johnson; Giulio Genovese; Ping An; David Friedman; William Briggs; Richard Dart; Stephen Korbet; Michele H Mokrzycki; Paul L Kimmel; Sophie Limou; Tejinder S Ahuja; Jeffrey S Berns; Justyna Fryc; Eric E Simon; Michael C Smith; Howard Trachtman; Donna M Michel; Jeffrey R Schelling; David Vlahov; Martin Pollak; Cheryl A Winkler
Journal:  J Am Soc Nephrol       Date:  2011-10-13       Impact factor: 10.121

7.  Higher risk for renal failure in first-degree relatives of white patients with end-stage renal disease: a population-based study.

Authors:  D F O'Dea; S W Murphy; D Hefferton; P S Parfrey
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

Review 8.  Health outcomes among non-Caucasian living kidney donors: knowns and unknowns.

Authors:  Krista L Lentine; Dorry L Segev
Journal:  Transpl Int       Date:  2013-03-27       Impact factor: 3.782

9.  Familial clustering of ESRD in the Norwegian population.

Authors:  Rannveig Skrunes; Einar Svarstad; Anna Varberg Reisæter; Bjørn Egil Vikse
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-04       Impact factor: 8.237

10.  Familial aggregation of renal disease in a population-based case-control study.

Authors:  H H Lei; T V Perneger; M J Klag; P K Whelton; J Coresh
Journal:  J Am Soc Nephrol       Date:  1998-07       Impact factor: 10.121

View more
  23 in total

Review 1.  Practical Considerations for APOL1 Genotyping in the Living Kidney Donor Evaluation.

Authors:  Alejandra M Mena-Gutierrez; Amber M Reeves-Daniel; Colleen L Jay; Barry I Freedman
Journal:  Transplantation       Date:  2020-01       Impact factor: 4.939

Review 2.  Understanding and Communicating Medical Risks for Living Kidney Donors: A Matter of Perspective.

Authors:  Krista L Lentine; Dorry L Segev
Journal:  J Am Soc Nephrol       Date:  2016-09-02       Impact factor: 10.121

3.  APOL1 Genotype and Renal Function of Black Living Donors.

Authors:  Mona D Doshi; Mariella Ortigosa-Goggins; Amit X Garg; Lihua Li; Emilio D Poggio; Cheryl A Winkler; Jeffrey B Kopp
Journal:  J Am Soc Nephrol       Date:  2018-01-16       Impact factor: 10.121

Review 4.  Risks of Living Kidney Donation: Current State of Knowledge on Outcomes Important to Donors.

Authors:  Krista L Lentine; Ngan N Lam; Dorry L Segev
Journal:  Clin J Am Soc Nephrol       Date:  2019-03-11       Impact factor: 8.237

5.  Gout after living kidney donation: correlations with demographic traits and renal complications.

Authors:  Ngan N Lam; Amit X Garg; Dorry L Segev; Mark A Schnitzler; Huiling Xiao; David Axelrod; Daniel C Brennan; Bertram L Kasiske; Janet E Tuttle-Newhall; Krista L Lentine
Journal:  Am J Nephrol       Date:  2015-04-17       Impact factor: 3.754

6.  KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.

Authors:  Krista L Lentine; Bertram L Kasiske; Andrew S Levey; Patricia L Adams; Josefina Alberú; Mohamed A Bakr; Lorenzo Gallon; Catherine A Garvey; Sandeep Guleria; Philip Kam-Tao Li; Dorry L Segev; Sandra J Taler; Kazunari Tanabe; Linda Wright; Martin G Zeier; Michael Cheung; Amit X Garg
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

7.  The changing landscape of live kidney donation in the United States from 2005 to 2017.

Authors:  Fawaz Al Ammary; Mary Grace Bowring; Allan B Massie; Sile Yu; Madeleine M Waldram; Jacqueline Garonzik-Wang; Alvin G Thomas; Courtenay M Holscher; Mohamud A Qadi; Macey L Henderson; Alexander C Wiseman; Jane Gralla; Daniel C Brennan; Dorry L Segev; Abimereki D Muzaale
Journal:  Am J Transplant       Date:  2019-05-03       Impact factor: 8.086

8.  Educating Prospective Kidney Transplant Recipients and Living Donors about Living Donation: Practical and Theoretical Recommendations for Increasing Living Donation Rates.

Authors:  Amy D Waterman; Mark L Robbins; John D Peipert
Journal:  Curr Transplant Rep       Date:  2016-01-26

9.  Gender differences in use of prescription narcotic medications among living kidney donors.

Authors:  Krista L Lentine; Ngan N Lam; Mark A Schnitzler; Amit X Garg; Huiling Xiao; Sheila E Leander; Daniel C Brennan; Sandra J Taler; David Axelrod; Dorry L Segev
Journal:  Clin Transplant       Date:  2015-09-18       Impact factor: 2.863

10.  Early Hypertension and Diabetes After Living Kidney Donation: A National Cohort Study.

Authors:  Courtenay M Holscher; Sunjae Bae; Alvin G Thomas; Macey L Henderson; Christine E Haugen; Sandra R DiBrito; Abimereki D Muzaale; Jacqueline M Garonzik Wang; Allan B Massie; Krista L Lentine; Dorry L Segev
Journal:  Transplantation       Date:  2019-06       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.